Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015673035> ?p ?o ?g. }
- W2015673035 endingPage "567" @default.
- W2015673035 startingPage "561" @default.
- W2015673035 abstract "BRAF is a member of the RAF kinase family, which acts in the ERK/MAP kinase pathway, a signalling cascade that regulates cellular proliferation, differentiation and survival. Single point mutations can turn BRAF into an oncogene, but there appears to be a cell type/tumour specific relevance for BRAF kinase-activating mutations, since they are found predominantly in cutaneous melanoma. With the success of targeting other oncogenic kinases such as BCR-ABL, KIT or members of the epidermal-growth factor receptor (EGFR) family in other cancers, the expectations were high when the first RAF kinase-targeting drug (sorafenib) reached clinical trials. However, disappointingly the first studies using sorafenib in melanoma patients did not show the anticipated single agent efficacy. More recently, the resolution of the BRAF crystal structure has led to the development of better, more specific BRAF inhibitors such as the Plexxikon compound, PLX4032, which induced a dramatic response rate in phase I trials, validating BRAF as a clinically relevant target. In addition, our understanding of melanoma biology and the role BRAF is playing therein has improved significantly. The complexity in the ERK/MAP kinase pathway including important feedback mechanisms has been dissected, and the relevance of cross-talks with other signalling pathways has been revealed, suggesting strategies for the design of improved, more efficient combinatorial therapies. This review highlights the relevance of BRAF and the ERK/MAP kinase pathway for melanoma cell biology and discusses some of the recent advances in both, the understanding of BRAF function in melanoma and the development of improved BRAF targeting inhibitors." @default.
- W2015673035 created "2016-06-24" @default.
- W2015673035 creator A5054179421 @default.
- W2015673035 creator A5082118845 @default.
- W2015673035 date "2010-09-01" @default.
- W2015673035 modified "2023-09-26" @default.
- W2015673035 title "BRAF as therapeutic target in melanoma" @default.
- W2015673035 cites W1493098692 @default.
- W2015673035 cites W1570494660 @default.
- W2015673035 cites W1571264139 @default.
- W2015673035 cites W1861331149 @default.
- W2015673035 cites W1883936019 @default.
- W2015673035 cites W1951705554 @default.
- W2015673035 cites W1966467063 @default.
- W2015673035 cites W1967835627 @default.
- W2015673035 cites W1967953130 @default.
- W2015673035 cites W1970195561 @default.
- W2015673035 cites W1970241639 @default.
- W2015673035 cites W1981711832 @default.
- W2015673035 cites W1982635732 @default.
- W2015673035 cites W1983575720 @default.
- W2015673035 cites W1987409389 @default.
- W2015673035 cites W2002918515 @default.
- W2015673035 cites W2003349514 @default.
- W2015673035 cites W2010684135 @default.
- W2015673035 cites W2022481874 @default.
- W2015673035 cites W2023037141 @default.
- W2015673035 cites W2028752124 @default.
- W2015673035 cites W2030365083 @default.
- W2015673035 cites W2032751670 @default.
- W2015673035 cites W2033290644 @default.
- W2015673035 cites W2034048944 @default.
- W2015673035 cites W2034450555 @default.
- W2015673035 cites W2035939293 @default.
- W2015673035 cites W2039482819 @default.
- W2015673035 cites W2040231284 @default.
- W2015673035 cites W2044029217 @default.
- W2015673035 cites W2045300715 @default.
- W2015673035 cites W2047669024 @default.
- W2015673035 cites W2048672579 @default.
- W2015673035 cites W2051165598 @default.
- W2015673035 cites W2051718122 @default.
- W2015673035 cites W2055972315 @default.
- W2015673035 cites W2060573548 @default.
- W2015673035 cites W2064448803 @default.
- W2015673035 cites W2066179587 @default.
- W2015673035 cites W2073363047 @default.
- W2015673035 cites W2074089133 @default.
- W2015673035 cites W2080686146 @default.
- W2015673035 cites W2095169768 @default.
- W2015673035 cites W2097010979 @default.
- W2015673035 cites W2102646127 @default.
- W2015673035 cites W2115218873 @default.
- W2015673035 cites W2116177733 @default.
- W2015673035 cites W2116629325 @default.
- W2015673035 cites W2121356082 @default.
- W2015673035 cites W2121886536 @default.
- W2015673035 cites W2122037714 @default.
- W2015673035 cites W2124662474 @default.
- W2015673035 cites W2125037724 @default.
- W2015673035 cites W2127120957 @default.
- W2015673035 cites W2131078803 @default.
- W2015673035 cites W2133776282 @default.
- W2015673035 cites W2134997705 @default.
- W2015673035 cites W2137705897 @default.
- W2015673035 cites W2139684524 @default.
- W2015673035 cites W2140765540 @default.
- W2015673035 cites W2144785546 @default.
- W2015673035 cites W2148171430 @default.
- W2015673035 cites W2149646251 @default.
- W2015673035 cites W2149662085 @default.
- W2015673035 cites W2150740687 @default.
- W2015673035 cites W2154196978 @default.
- W2015673035 cites W2155381255 @default.
- W2015673035 cites W2160378889 @default.
- W2015673035 cites W2161080185 @default.
- W2015673035 cites W2161614082 @default.
- W2015673035 cites W2161724145 @default.
- W2015673035 cites W2163188200 @default.
- W2015673035 cites W2164134009 @default.
- W2015673035 cites W2164154120 @default.
- W2015673035 cites W2166271687 @default.
- W2015673035 cites W2167039800 @default.
- W2015673035 cites W2169209908 @default.
- W2015673035 cites W2169336337 @default.
- W2015673035 cites W2241837682 @default.
- W2015673035 cites W2248216542 @default.
- W2015673035 doi "https://doi.org/10.1016/j.bcp.2010.03.019" @default.
- W2015673035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20350535" @default.
- W2015673035 hasPublicationYear "2010" @default.
- W2015673035 type Work @default.
- W2015673035 sameAs 2015673035 @default.
- W2015673035 citedByCount "145" @default.
- W2015673035 countsByYear W20156730352012 @default.
- W2015673035 countsByYear W20156730352013 @default.
- W2015673035 countsByYear W20156730352014 @default.
- W2015673035 countsByYear W20156730352015 @default.
- W2015673035 countsByYear W20156730352016 @default.